伊索特里诺因的幕后:我的旅程和建议
1University of Tennessee Health Science Center, Memphis, TN, USA.
Journal of patient experience
|November 5, 2024
概括
治疗严重的维生素A衍生物伊索特里诺因 (Isotretinoin) 可能会引起令人衰弱的副作用. 皮肤科医生应该加强患者咨询和共享决策,而iPLEDGE REMS系统可以改善症状跟踪.
科学领域:
- 皮肤病学 皮肤病学
- 药理学 药理学是指药理学的学科.
- 患者安全 患者安全
背景情况:
- 伊索特里诺因是一种维生素A衍生物,用于严重的,复发性.
- 治疗持续时间通常在3至12个月之间.
- 显著的身体和精神副作用需要密切监测.
研究的目的:
- 强调对异三因进行全面的风险效益分析的重要性.
- 倡导改善患者与医疗服务提供者之间关于副作用的沟通.
- 建议对iPLEDGE REMS程序进行改进,以更好地控制症状.
主要方法:
- 对与异二胺的个人经验进行定性分析.
- 审查目前的风险管理策略 (iPLEDGE REMS).
- 讨论皮肤病护理中的患者-提供者沟通.
主要成果:
- 异丁治疗可能会导致独特且严重削弱身体和精神的副作用.
- 当前的风险管理计划可能无法完全解决患者对副作用的经验.
- 需要加强患者教育和共享决策.
结论:
- 皮肤科医生应优先考虑共享决策,介绍所有治疗选择,并详细讨论异丁胺的风险和益处.
- 在每月检查期间关于副作用的公开对话对于减轻患者的恐惧和羞耻至关重要.
- 在iPLEDGE REMS框架内系统的症状记录可以使患者的体验正常化,并完善治疗策略.
相关概念视频
Drug Biotransformation: Overview
2.3K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.3K
Drug Administration and Therapy Phases: Overview
411
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
411
Methods for Studying Drug Absorption: In situ
208
In situ experiments, such as the Doluisio method and Single-Pass Perfusion technique, provide critical insights into drug uptake by simulating in vivo conditions for drug absorption.
The Doluisio method involves perfusing a prepared segment of a rat's small intestine with a solution of radiolabeled drug and a non-absorbable marker. This helps to differentiate between absorbed and non-absorbed drug concentrations. The intestinal segment is connected at both ends using tubing and syringes,...
The Doluisio method involves perfusing a prepared segment of a rat's small intestine with a solution of radiolabeled drug and a non-absorbable marker. This helps to differentiate between absorbed and non-absorbed drug concentrations. The intestinal segment is connected at both ends using tubing and syringes,...
208
Drug Absorption: Overview
531
The process of drug absorption signifies the transition of a drug from its site of administration into the plasma. This process is influenced by various factors, including the route of administration, the anatomy of the absorption site, the mechanism of absorption, gut motility, and the drug's physicochemical properties.
When drugs are injected intravenously, they directly enter the systemic circulation. Alternatively, orally administered drugs navigate through the gastrointestinal (GI)...
When drugs are injected intravenously, they directly enter the systemic circulation. Alternatively, orally administered drugs navigate through the gastrointestinal (GI)...
531
Factors Influencing Drug Absorption: Presystemic Elimination
183
The pharmacokinetic journey of oral drugs begins with a crucial first pass through the hepatic portal system, called the first-pass effect. This first pass significantly impacts bioavailability — the proportion of a drug that enters systemic circulation and is available for therapeutic action. The primary route sees the drug absorbed by intestinal membranes and then shunted to the liver via the hepatic portal vein. Here, pre-systemic elimination occurs as drugs face metabolism or biliary...
183
Factors Influencing Drug Absorption: Pharmaceutical Parameters
121
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
121


